Release date: 2008-09-11
 

Diapharm Starts GMP Audit Service for Active Pharmaceutical Ingredients
 

(Newswire Today) —  Muenster, North Rhine-Westfalia, Germany, 2008-09-11 - Pharma service provider Diapharm is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs).

   
 

Pharma service provider Diapharm is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs). In a shared audit several medicinal product manufacturers jointly commission the check of production conditions for a starting material or API such as ibuprofen or naproxen. The resulting audit report serves to prove whether the rules of good manufacturing practice (GMP) are followed in the manufacture of the ingredient. This proof of GMP compliance is mandatory for European manufacturers of medicinal products. “Accredited third-party audits offer additional security, since they are also recognized internationally by the authorities”, explains Dorothee Klöpf of Diapharm, responsible for the GMP audit service. For these checks Diapharm collaborates with the independent, accredited blue inspection body GmbH. Upon request, blue also undertakes the management of deficiencies.

About 80 percent of the starting materials and APIs used in the production process of medicinal products in Europe come from third countries such as India or China. With the shared audit concept, Diapharm spreads the cost of auditing the APIs among several parties, interested medicinal product manufacturers in Europe who jointly commission an audit of an API manufacturer.

For the 4th quarter of 2008 Diapharm (diapharm.com) is coordinating shared-audit trips to China and India. Audits are to be made of, among others, manufacturers of acetylsalicylic acid, atorvastatin, ciprofloxacin, caffeine, donepezil, hydrocortisone, ibuprofen, levofloxacin, lovastatin, metamizole, naproxen, naratriptan, paracetamol, pravastatin, propyphenazone, rizatriptan, rosiglitazone, rosuvastatin, simvastatin, sotalol, sumatriptan, theophylline, trimethoprim and zolmitriptan. Diapharm also supplies ready-made GMP audit reports for a steadily increasing number of starting materials and APIs.

   
 

Agency / Source:

 
 
# # #
 
  Related Link:
 Contact name: Nicole Sibbing
  Related Link:
 +49 (0)251 60935-11 / karin.mueller[.]diapharm.com
PRZOOM disclaims any content contained in these release. Our complete disclaimer appears on our disclaimer page. Issuers of releases are solely responsible for the accuracy of their content. All trademarks are the property of their respective owners.
© PRZOOM.com - NewswireToday.com - Press Release & Newswire Distribution Network.


Reserve This Permanent SPACE

Your LOGO permanently HERE on Newswire Today most visited Page start at $295 per month

 
Sponsored Links


Visit  Invis Multimedia

Visit  London Choice®









Skype callphones







 
  ©2009 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise | Find Articles | Contact | Investors | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report news market search pr firms pr agencies business reports newswire distri- bution today investor relation successful internet entrepreneur free newswire distribution freenewswiredistribution.com asianewstoday bizwiretoday pr-newswire-today